DNA polymerase theta up-regulation is associated with poor survival in breast cancer, perturbs DNA replication, and promotes genetic instability.
Lemée F, Bergoglio V, Fernandez-Vidal A, Machado-Silva A, Pillaire MJ, Bieth A, Gentil C, Baker L, Martin AL, Leduc C, Lam E, Magdeleine E, Filleron T, Oumouhou N, Kaina B, Seki M, Grimal F, Lacroix-Triki M, Thompson A, Roché H, Bourdon JC, Wood RD, Hoffmann JS, Cazaux C.
Proc Natl Acad Sci U S A. 2010 Jul 27 ;107(30):13390-5.
Improved outcome with pulses of vincristine and corticosteroids in continuation therapy of children with average risk acute lymphoblastic leukemia (ALL) and lymphoblastic non-Hodgkin lymphoma (NHL) : report of the EORTC randomized phase 3 trial 58951.
De Moerloose B, Suciu S, Bertrand Y, Mazingue F, Robert A, Uyttebroeck A, Yakouben K, Ferster A, Margueritte G, Lutz P, Munzer M, Sirvent N, Norton L, Boutard P, Plantaz D, Millot F, Philippet P, Baila L, Benoit Y, Otten J ; Children’s Leukemia Group of the European Organisation for Research and Treatment of Cancer (EORTC).
Blood. 2010 Jul 8 ;116(1):36-44.
Bortezomib Plus Dexamethasone Induction Improves Outcome of Patients With t(4 ;14) Myeloma but Not Outcome of Patients With del(17p).
Avet-Loiseau H, Leleu X, Roussel M, Moreau P, Guerin-Charbonnel C, Caillot D, Marit G, Benboubker L, Voillat L, Mathiot C, Kolb B, Macro M, Campion L, Wetterwald M, Stoppa AM, Hulin C, Facon T, Attal M, Minvielle S, Harousseau JL.
J Clin Oncol. 2010 Jul 19. PMID : 20644101
IgA-mediated human autoimmune hemolytic anemia as a result of hemagglutination in the spleen, but independently of complement activation and FcalphaRI.
Chadebech P, Michel M, Janvier D, Yamada K, Copie-Bergman C, Bodivit G, Bensussan A, Fournie JJ, Godeau B, Bierling P, Izui S, Noizat-Pirenne F.
Blood. 2010 Jul 19. PMID : 20644119
Common variants associated with breast cancer in genome-wide association studies are modifiers of breast cancer risk in BRCA1 and BRCA2 mutation carriers.
Wang X, Pankratz VS, Fredericksen Z, Tarrell R, Karaus M, McGuffog L, Pharaoh PD, Ponder BA, Dunning AM, Peock S, Cook M, Oliver C, Frost D ; EMBRACE, Sinilnikova OM, Stoppa-Lyonnet D, Mazoyer S, Houdayer C ; GEMO, Hogervorst FB, Hooning MJ, Ligtenberg MJ ; HEBON, Spurdle A, Chenevix-Trench G ; kConFab, Schmutzler RK, Wappenschmidt B, Engel C, Meindl A, Domchek SM, Nathanson KL, Rebbeck TR, Singer CF, Gschwantler-Kaulich D, Dressler C, Fink A, Szabo CI, Zikan M, Foretova L, Claes K, Thomas G, Hoover RN, Hunter DJ, Chanock SJ, Easton DF, Antoniou AC, Couch FJ.
Hum Mol Genet. 2010 Jul 15 ;19(14):2886-97.
Emerging concepts for the treatment of hematological malignancies with therapeutic monoclonal antibodies.
Capietto AH, Keirallah S, Gross E, Dauguet N, Laprévotte E, Jean C, Gertner-Dardenne J, Bezombes C, Quillet-Mary A, Poupot M, Ysebaert L, Laurent G, Fournié JJ.
Curr Drug Targets. 2010 Jul ;11(7):790-800.
A new recurrent translocation t(11 ;14)(q24 ;q32) involving IGH@ and miR-125b-1 in B-cell progenitor acute lymphoblastic leukemia.
Chapiro E, Russell LJ, Struski S, Cavé H, Radford-Weiss I, Valle VD, Lachenaud J, Brousset P, Bernard OA, Harrison CJ, Nguyen-Khac F.
Leukemia. 2010 Jul ;24(7):1362-4.
The silencing of microRNA 148a production by DNA hypermethylation is an early event in pancreatic carcinogenesis.
Hanoun N, Delpu Y, Suriawinata AA, Bournet B, Bureau C, Selves J, Tsongalis GJ, Dufresne M, Buscail L, Cordelier P, Torrisani
J. Clin Chem. 2010 Jul ;56(7):1107-18.
Prophylaxis of invasive aspergillosis with voriconazole or caspofungin during building work in patients with acute leukemia.
Chabrol A, Cuzin L, Huguet F, Alvarez M, Verdeil X, Linas MD, Cassaing S, Giron J, Tetu L, Attal M, Récher C.
Haematologica. 2010 Jun ;95(6):996-1003.
Tandem versus single autologous peripheral blood stem cell transplantation as post-remission therapy in adult acute myeloid leukemia patients under 60 in first complete remission : results of the multicenter prospective phase III GOELAMS LAM-2001 trial.
Chevallier P, Fornecker L, Lioure B, Béné MC, Pigneux A, Recher C, Witz B, Fegueux N, Bulabois CE, Daliphard S, Bouscary D, Vey N, Delain M, Bay JO, Turlure P, Bernard M, Himberlin C, Luquet I, Ifrah N, Harousseau JL ; GOELAMS.
Leukemia. 2010 Jul ;24(7):1380-5.
Mutations in TP53 are exclusively associated with del(17p) in multiple myeloma.
Lode’ L, Eveillard M, Trichet V, Soussi T, Wuilleme S, Richebourg S, Magrangeas F, Ifrah N, Campion L, Traulle C, Guilhot F, Caillot D, Marit G, Mathiot C, Facon T, Attal M, Harousseau JL, Moreau P, Minvielle S, Avet-Loiseau H.
Haematologica. 2010 Jul 15. PMID : 20634494
Coregistration of Prechemotherapy PET-CT for Planning Pediatric Hodgkin’s Disease Radiotherapy Significantly Diminishes Interobserver Variability of Clinical Target Volume Definition.
Metwally H, Courbon F, David I, Filleron T, Blouet A, Rives M, Izar F, Zerdoud S, Plat G, Vial J, Robert A, Laprie A.
Int J Radiat Oncol Biol Phys. 2010 Jul 7. PMID : 20615626